Category: Pharmaceuticals
Roche’s cancer immunotherapy shrank tumors in 24% of patients
Roche recently announced that its IMvigor210, Tecentriq (atezolizumab), in a Phase II study, shrank tumors in 24% of people with locally advanced or metastatic urothelial carcinoma (mUC) who have not received a prior first-line treatment and who were ineligible for […]
Plastikos introduces COC cartridge components for drug delivery market
The Erie, Pennsylvania-based custom injection molder and mold-making sister companies, Plastikos Inc. and Micro Mold, respectively, have successfully commercialized disposable cartridge components made of cyclic olefin copolymer (COC) for wearable drug delivery devices for medications such as insulin and pain […]
Clariant Healthcare Packaging introduces new Aroma-Can canisters
Clariant, a Switzerland-based global specialty chemicals company, and its Healthcare Packaging unit, is launching a new and improved family of Aroma-Cancanisters to enhance nutritional products by adding a pleasant scent to product packaging. Modeled after Clariant’s desiccant canisters for pharmaceutical […]
Pfizer orders restriction for the use of its drugs in lethal injections
Pfizer, an American global pharmaceutical corporation, released their position against the use of its products in lethal injections for capital punishment. According to their statement, the company’s mission is to apply science and its global resources to improve health and […]
Painkiller acetaminophen also reduces empathy for others’ pain
A new study suggests that the popular painkiller acetaminophen reduces pain but it may also decrease empathy for both the physical and social aches that other people experience. For example, researchers at The Ohio State University foundthat when participants who […]
Gates Foundation gives US$38 million grant to Takeda polio vaccine
Takeda Pharmaceutical Company Limited, a Japan-based global, R&D-driven pharmaceutical company, announced today a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries.Takeda will develop, license and supply at least 50 million doses per […]
US FDA approves Acadia drug for psychosis linked to Parkinson’s
Acadia Pharmaceuticals Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin), an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. In 2014, the FDA designated Nuplazid as […]
Sanofi offers to acquire US cancer drug firm Medivation for US$9.3 billion
Sanofi, a French multinational pharmaceutical company, announced on April 28 that it has sent a letter to Medivation Inc., making a non-binding proposal to acquire Medivation for US$52.50 per share. This would represent an all-cash transaction valued at approximately US$9.3 […]
GW Pharma’s cannabis drug granted orphan drug status by US FDA
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform,announced on April 21 that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for cannabidiol (CBD) for […]
Over-the-counter drugs linked to cognitive decline and dementia
People often overlook the warnings that come with over-the-counter drugs as they go on the quest to find quick remedies for medical problems ranging from allergies to insomnia. Researchers at the Indiana University School of Medicine published a new study […]
